-+ 0.00%
-+ 0.00%
-+ 0.00%

The State Drug Administration held an administrative meeting. The conference called for adhering to steady progress, deepening reforms in key areas with greater vigour, grasping the pace, clarifying direction, strengthening collaboration, empowering industrial innovation and increasing efficiency, and building a strong barrier to quality and safety. It is necessary to speed up the establishment of a precautionary supervision model, conduct in-depth risk consultations, innovate social co-governance methods, and effectively prevent safety risks in key areas. It is necessary to establish a “service+review and approval” mechanism to accelerate the transformation of results through efficient services, support the high-quality development of generic drugs, strengthen drug use guarantees for special groups, and expand high-level openness to the outside world. It is necessary to improve supervisory capabilities, push forward the implementation of plans as soon as possible, improve the technical supervision system, strengthen talent training, and speed up the construction of smart supervision. It is necessary to strengthen party building leadership, refine an excellent style of work, carry out in-depth “Qinglang Drug Supervisory” special reform, and motivate responsible action.

Zhitongcaijing·08/24/2026 11:25:03
Listen to the news
The State Drug Administration held an administrative meeting. The conference called for adhering to steady progress, deepening reforms in key areas with greater vigour, grasping the pace, clarifying direction, strengthening collaboration, empowering industrial innovation and increasing efficiency, and building a strong barrier to quality and safety. It is necessary to speed up the establishment of a precautionary supervision model, conduct in-depth risk consultations, innovate social co-governance methods, and effectively prevent safety risks in key areas. It is necessary to establish a “service+review and approval” mechanism to accelerate the transformation of results through efficient services, support the high-quality development of generic drugs, strengthen drug use guarantees for special groups, and expand high-level openness to the outside world. It is necessary to improve supervisory capabilities, push forward the implementation of plans as soon as possible, improve the technical supervision system, strengthen talent training, and speed up the construction of smart supervision. It is necessary to strengthen party building leadership, refine an excellent style of work, carry out in-depth “Qinglang Drug Supervisory” special reform, and motivate responsible action.